Hadassah Southern New Jersey

08/24/2026

What a year of impact. 💙

Tap the link in the comment section to explore the 2025 Impact Report.

08/24/2026

A new direction for treating a deadly brain cancer. 🧠

A first in Israel. A new direction for treating a deadly brain cancer. 🧠

For the first time in Israel, neurosurgeons at the Hadassah Medical Organization have used intracranial Alpha DaRT® radiation therapy to treat a patient with recurrent glioblastoma — one of the most aggressive and difficult-to-treat brain tumors.

Led by Dr. Yigal Shoshan, HMO director of Neurosurgery, Oncology and Stereotactic Radiosurgery, the procedure is part of a Phase 1 clinical trial exploring a potentially new approach to treating recurrent glioblastoma.

What makes Alpha DaRT different? The technology delivers highly localized alpha radiation directly within the tumor, with the goal of maximizing tumor destruction while minimizing exposure to surrounding healthy brain tissue.

And in a world first, Dr. Shoshan and his team used two simultaneous trajectories to implant the radiation sources into a large tumor while maintaining precision.

This moment represents years of work — from laboratory research and preclinical studies to technological development and, now, clinical application.

“Seeing the technology reach a patient in Israel for the first time was an exciting moment for everyone who has been part of this journey,” said Dr. Shoshan.

It’s a powerful reminder of what can happen when research, technology and clinical expertise come together to pursue new possibilities for patients.

Tap the link in the comment section to read the full story.

08/19/2026

Urge Congress to act.
Tap the link in the comments.

More than 300,000 women in the United States are diagnosed with breast cancer every year, and early detection saves lives. Yet, high out-of-pocket costs and limited access to screening delay care.

For , tap the link in the comment section to, urge Congress to support bipartisan legislation expanding access to lifesaving breast cancer screening and care.

08/16/2026

The attack at Central Synagogue in NYC during Friday night services is deeply disturbing. No one in any faith community should have to wonder whether they are safe simply because they have come together to worship. We are grateful for the swift response of law enforcement and synagogue security and for everyone who worked to protect those inside.

This is yet another troubling incident as antisemitism continues to rise. We cannot ignore the connection between words that vilify, dehumanize and demonize the Jewish community and the actions that can follow. Nor can we ignore the role that inflammatory anti-Israel rhetoric plays in fueling antisemitism.

We each have a responsibility to speak out against antisemitism. In the public and private sector, those in leadership carry a responsibility to call it out and reject rhetoric that puts Jewish people in danger.

08/14/2026

Less hustle. More Shabbat. ✨

The to-do list can wait. Shabbat is the perfect time to slowdown and recharge.

Shabbat Shalom! 💙

08/14/2026

Do you know the Jewish story behind Mr. and Mrs. Potato Head?
Join us on August 20 at 7 PM ET.
Save your spot! Register now
🔗 link in comments

08/13/2026

Woo-hoo!

🥉 Can we get a woo-hoo? 🥉

Daniel Vorbyev, an 11th-grade student at Hadassah Neurim Youth Aliyah Village, is returning from the International Olympiad in Artificial Intelligence (IOAI) with an individual honorable mention as part of the Israeli delegation that won a bronze team medal.
This was the first time Israel competed in the IOAI, which brought together 480 students from 108 countries this year in Kazakhstan. The Israeli delegation was made up of students who train on Israel's prestigious National Computer Science Team, selected from thousands of students across the country.

Read more —> Link in comments.
🥉 Hadassah Neurim כפר הנוער הדסה נעורים

08/11/2026

Congratulations!

Congratulations to the Hadassah Medical Organization researchers and physician-scientists who’ve earned 2026 Israel Science Foundation (ISF) grants.

These awards reflect the scientific excellence, innovation and dedication of Hadassah's research community. The ISF, Israel's leading organization for supporting basic scientific research, enables researchers to pursue groundbreaking discoveries, strengthen academic collaborations, and advance the future of medicine.
�
The Hadassah 2026 award recipients:

Individual Research Grants
• Prof. Esi Esther Sharon Sagie - Oral Rehabilitation
• Prof. Nurit Beyth - Oral Rehabilitation
• Prof. Alexander Gural - Hematology
• Dr. Liya Kerem - Pediatrics

MAVRI Biomedical Research Grants:
• Prof. Michal Lotem - Oncology
• Prof. Eithan Galun - Gene Therapy
• Prof. Iris Lavon - Neurology
• Dr. Gal Goldstein - Pediatric Hemato-Oncology
• Dr. Yonatan Zarbiv - Oncology
• Dr. Gilad Karavani - Obstetrics and Gynecology
• Prof. Ran Nir-Paz - Clinical Microbiology & Infectious Diseases
• Dr. Boaz Nachmias - Hematology
• Dr. Abed Khalaileh - Surgery
• Dr. Imam Ashraf- Surgery
• Prof. Ayala Hubert - Oncology

MAVRI Start-up Grant for Physician-Scientists:
• Prof. Alex Gileles-Hillel - Pediatric Pulmonology

08/07/2026

Hadassah Southern New Jersey celebrated Hadassah Lifechangers - presenting an award to Elie Honig with the Associates Leadership and Commitment Award for his professional accomplishments and dedication to Jewish values. He shared highlights of his personal heritage and impressive career in law, public service, journalism, and advocacy.

We also celebrated Chapter Associates Awards to Paul Altschuler, Dan Bershad, Bob Charen, Alan Finkelstein, Mickey Kaufman, Gary Moliver, Dov Pollack, Robert Shimony.

Past Hadassah National President Ellen Hershkin shared her personal story of inspiration for joining Hadassah and how the mission, people, and positive impact on so many lives keeps her engaged, motivated and inspired!

Thanks to our Region Presidents Debbie Glick and Kim Wishnow-Per , event co-chairs Carol Charen and Judy Neuman, and all who helped or came out to support these wonderful leaders.